Referencias

1. Dorantes MS. Diagnóstlco de los problemas hematológicos en pediatría. México: Asociación de Médicos del Hospital Infantil de México, 1971.

2. Bello A. Hematología Básica. México:Ediciones Médicas del Hospital Infantil de México, 1983:25.

3. Mejía DAM, Mejía DS, Dorantes MS, Vigueras RA. Valores de la serie roja, leucocitos y plaquetas en las primeras ocho semanas de vida a 2,650 metros de altitud. Bol Med Hosp Infant Mex 1985; 42: 297.

4. Farfán CJM, Alvarez AC, Benítez-Aranda H, Bernáldez RR, Juan SL. Hematología. En: Manual de procedimientos médico-quirúrgicos. Hospital de Pediatría, Centro Médico Nacional Siglo XXI. México: Méndez Editores, 1993: 16-1-16-36.

5. Fairbanks VF, Beutler E. Iron deficiency. En: Beutler E, Lichtman MA, Coller BS, Kipps TJ, ed. Williams Hematology. Fifth ed. New York:McGraw-Hill, 1995; 490-511.

6. Dallman PR, Yip R, Oski FA. Iron deficiency and related nutritional anemias. En: Nathan DG, Oski FA, ed. Hematology of infancy and childhood. 4th ed. Philadelphia: WB Saunders, 1993: 413-450.

7. Benítez-Aranda H. Anemia por deficiencia de hierro. Rev Mex Pediatr 1982; 49: 229.

8. Vázquez SJ, Benítez H, Azuara MC, De la Rosa LO, Killner S, Casillas L. Frecuencia de anemia en 1,545 estudiantes de primer ingreso a la UNAM. Salud Publica Mex 1978; 20: 485.

9. Lozoff B, Brittenham GM. Iron deficiency anemia and iron therapy effects on infant developmental test performance. Pediatrics 1987; 79:981.

10. Walter T, De Andraca I. Iron deficiency anemia: adverse effects on infant psychomotor development. Pediatrics 1989; 84:7.

11. Pollit E, Hathirat P. Iron deficiency and educational achievement in Thailand. Am J Clin Nutr 1989; 50:687.

12. Babior BM. The megaloblastic anemias. En: Beutler E, Lichtman MA, Coller BS, Kipps TJ, ed. Williams Hematology. Fifth ed. New York: McGraw-Hill, 1995:471-489.

13. Cooper BA, Rosenblatt DS, Whitehead VM. Megaloblastie anemia. En: Nathan DG, Oski FA, ed. Hematology of infaney and childhood. 4th ed. Philadelphia: WB Saunders, 1993:354-390.

14. Shojania M. Folic acid and vitamin B12 deficiency in pregnancy and in the neonatal period. Clin Perinatol 1984;11:2.

15. Trier JS. Celiac sprue. N Engl J Med 1991; 325:1709.

16. Davis JH, Goldenring J, Lubin BH. Nutritional vitamin B12 deficiency in infants. Am J Dis Child 1981; 135:566.

17. Graham SM, Arvela OM, Wise GA. Longterm neurologic consequences of nutritional vitamin B12 deficiency in infants. J Pediatr 1992; 121:710.

18. Askkenazi S,Weitz R. Vitamin B12 deficiency due to a strictly vegetarian diet in adolescence. Clin Pediatr 1987; 26:662.

19. Skidmore MD, Shenker N. Biochemical evidence of asymptomatic B12 deficiency in children after ileal resection for necrotizing enterocolitis. J Pediatr 1989; 115:102.

20. Lindenbaum J, Nath BJ. Megaloblastic anaemia and neutrophil hypersegmentation. Br J Haematol 1980, 44:511.

21. Sánchez-Medal L, Dorantes S. Aplastic anemia. Pediatrician 1974, 3:74.

22. Camitta BM, Storb R, Thomas ED. Aplastic anemia. N Engl J Med 1982, 306:645.

23. Bernaldez RR, Benítez-Aranda H, Castañeda TE, Esparza FMA, Alvarez AC, Farfán CJM. Anemia de Fanconi. Bol Med Hosp Infant Mex 1985; 42:435.

24. Benítez Aranda H, Farfán CJM, Velázquez E. Disqueratosis congénita con anemia aplástica. Bol Med Hosp Infant Mex 1988; 45:846.

25. Dorantes S. Simposio sobre anemia aplástica. Gac Med Mex 1989; 125:341.

26. Benítez-Aranda H, Farfán CJM. Anemia aplástica adquirida. Bol Med Hosp Infant Mex 1994; 51:132.

27. Silver BJ, Zuckerman KS. Aplastic anemia. Recent advances in pathogenesis and treatment. Med Clin North Am 1980; 64:607.

28. Sieff CA, Nathan DG. The anatomy and physiology of hematopoiesis. En: Nathan DG, Oski FA, ed. Hematology of infancy and childhood. 4th ed. Philadelphia: WB Saunders, 1993: 156-215.

29. Aksoy M, Erdem S, Dincol G, Bakioglu I, Kutlar A. Aplastic anemia due to chemicals and drugs: a study of 108 patients. Sex Transm Dis 1984; 11(supl):347.

30. Juárez J, Benítez H, Izquierdo J, Marin T, Dueñas MT, Zarzosa E, Ortíz A, López G, Jiménez E. Environmental factors and mielotoxic agents in adquired aplastic anemia in children. Rev Invest Clin 1994; Supl:231.

31. Plaut ME, Best WR. Aplastic anemia after parenteral chloramphenicol: warning renewed. N Engl J Med 1982, 306:1186.

32. Del Valle F, Ramos S, Dorantes MS, Paredes E, Escanero A, Alejandre BJA. Resultado del tratamiento temprano de la hemorragia intracraneal en niños con anemia aplástica. Bol Med Hosp Infant Mex 1984; 41:645.

33. Killner M, Takane J, Dorantes S, y col. Manifestaciones de la anemia refractaria en vías respiratorias superiores y cavidades anexas. Bol Med Hosp Infant Mex 1972; 29:12.

34. Benítez AH, González BE, Fajardo GA, Farfán CJM, Juan SL, Bernáldez RR, Leaños MB, Ahedo CJ. Riesgo relativo de infecciones en pacientes pediatricos con anemia aplástica adquirida severa. Bol Med Hosp Infant Mex 1993; 50:697.

35. Camitta BM, Storb R, Thomas ED. Aplastic anemia. N Engl J Med 1982; 306:712.

36. Davis S, Rubin AD. Treatment and prognosis in aplastic anaemia. Lancet 1972; 1:871.

37. Najean Y. Joint Group for the Stuy of Aplastic and Refractory Anemias. Long-term followup in patients with aplastic anemia. A study of 137 androgen-treated patients surviving more than two years. Am J Med l981;71:543.

38. Dorantes S, Vázquez J, Soto R, Toro AH, Arias J, Bello A, y col. El pronóstico de la anemia refractaria. Bol Med Hosp Infant Mex 1965; 22:91.

39. Alférez JG, Dorantes S, Joachin A, Bello A, Márquez JL. Relación entre el agente etiológico de un proceso infeccioso en pacientes con anemia refractaria y las modificaciones en el número de neutrófilos. Bol Med Hosp Infant Mex 1969; 26:573.

40. Benítez-Aranda H, Sánchez GB, Esparza FMA, Ortiz FA, Fernández RR, Alvarez AC, y col. Tratamiento de la anemia aplástica adquirida severa en niños. Estudio comparativo. Bol Med Hosp Infant Mex 1991; 48:607.

41. Ancieta M, Benítez H, Alvarez MT, Vázquez G,Farfán J,Juan L,Mejía JM. Prevalence for viral infections in multiple blood transfusions hematological pediatric patients: study of risk factors. Rev Invest Clin 1994; Supl: 326.

42. Locasciulli A, van't Veer L, Bacigalupo A, Hows J, Van Lint MT, Gluckman E, y col. Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from EBMT SAA Working Party. Bone Marrow Transplant 1990; 6:211.

43. Bello SA, Márquez JL, Guerrero VE, Zavala H, Arvizu JR, Encarnación A, Rodríguez RS, Sánchez M, Benítez-Aranda H, Farfán CJM, Alfaro MJ, Marín T, Izquierdo J, Dueñas MT, Morales-Polanco M, Gómez E, Sánchez VE, Guerrero S, Ferrer VE, Fuentes J, VázquezE, Gutiérrez M, Paredes R, Mejía D, Maldonado A, for the Aplastic Anemia Study Group of Mexico. Observation on treatment of 71 cases of aplastic anemia in children. Rev Invest Clin 1994; Supl:187.

44. Frichofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, y col. Treatment of aplastic anemia with antilimphocyte globulin and methylprednisolone with or without cyclosporine. N Engl JMed 1991; 324:1297.

45. Bacigalupo A, Chaple M, Hows J, van Lint MT, McCann S, Milligan D, y col. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (M Pred) with or without androgens: a randomized trial from the EBMT SAA working party. Br J Haematol 1993; 83:145.

46. Nissen C, Gratwohl A, Tichelli A, Stebler C, Wursch A,Moser Y, y col. Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia. Br J Haematol 1993; 83:319.

47. Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Youg NS. Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol 1989, 72:278.

48. Werner EJ, Stout RD, Valdez LP, Harris RE. Immunosupressive therapy versus bone marrow transplantation for children with aplastic anemia. Pediatrics 1989; 83:61.

49. Boxer LA, Hutchinson R, Emerson S. Recombinant human granulocyte colony- stimulating factor in the treatment of patients with neutropenia. Clin Immunol Immunopathol 1992; 62:S39.

50. Kojima S~ Fukuda M, Miyajima Y, Matsuyama T, Horibe K. Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood 1991; 77:937.

5l. Alter BP,Young NS. The bone marrow failure syndromes. En: Nathan DG, Oski FA, ed. Hematology of infancy and childhood. 4th ed . Philadelphia: WB Saunders, 1993; 216-316.

52. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registery: Relation of clinical symptoms to diepoxybutane sensivity. Blood 1989; 73:391.

53. Alter BP. Fanconi's anemia: Current concepts. Am J Pediatr Hematol Oncol 1992; 14:170.

54. Shadduck RK. Aplastic anemia. En: Beutler E, Lichtman MA, Coller BS, Kipps TJ, ed. Williams Hematology. Fifth ed. New York: McGraw-Hill, 1995; 238-251.

55. Dosik H,Steir W,Lubiniecki A.Inherited aplastic anaemia with increased endoreduplications: a new syndrome or Fanconi's anaemia variant? Br J Haematol 1979; 41:77.

56. Dosik H, Hsu LY, Todaro JG, y col. Leukemia in Fanconi's anemia: cytogenetic and tumor virus susceptibility studies. Blood 1970; 36:341.

57. Gordon-Smith EC, Rutherford TR. Fanconi anemia: Constitutional aplastic anemia. Semin Hematol 1991, 28:104.

58. McDonald R, Mibashan RS. Prolonged remission in Fanconi type anemia. Helv Paediatr Acta 1969; 23:566.

59. Obeid JA, Hill FHG, Harnden D, Mann JR, Wood BSB. Fanconi anemia. Oxymetholone, hepatic tumors, and chromosome aberrations associated with leukemic transition. Cancer 1980; 46:1401.

60. Hamre MR, Kirkpatrick DV, Humbert JR. Squamous cell carcinoma of the tongue in a patient with Fanconi anemia post bone marrow transplant. Pediatr Res 1989; 25:151A.

61. Hanada T, Abe T, Nakazawa M, Aoki Y, Uyeno K. Bone marrow failure in dyskeratosis congenita. Scand J Haematol 1984; 32:496.

62. Friedland M, Lutton JD, Spitzer R, Levere RD. Dyskeratosis congenita with hypoplastic anemia: a stem cell defect. Am J Hematol 1985, 20:85.

63. Del Angel GO, Dorantes MS, Redón TA. Anemia aplástica en disqueratosis congénita. Bol Med Hosp Infant Mex 1986; 43:176.

64. Jacobs P, Saxe N, Gordon W, Nelson M. Dyskeratosis congenita. Scand J Haematol 1984; 32:461.

65. Pai GS, Morgan S, Whetsell C. Etiologic heterogeneity in dyskeratosis congenita. Am J Med Genet 1989, 32:63.

66. Conter V, Johnson FL. Bone marrow transplantation for aplastie anemia associated with dyskeratosis congenita. Am J Pediatr Hematol Oncol 1988; 10:99.

67. Benítez-Aranda H, Olivares CG, Izquierdo RJ, Farf n CJM, Rodríguez ZMC. Aplasia seleetiva congénita de la serie roja. Estudio de 13 casos. Bol Med Hosp Infant Mex 1988; 45:89.

68. Benjamin E. Ueber eine selbstandige form der anamie im frühen Kindesalter. Verhandl. d Versamml d. Gesellsch f. Kinderh Deutsch Naturf u Aerste 1911; 28:119. Citado por Diamond LK(69).

69. Diamond LK, Allen DM, Magill FB. Congenital (eryhroid) hypoplastic anemia. Am J Dis Child 1961; 102:149.

70. Josephs HW. Anaemia of infancy and early childhood. Medicine 1936; 15:401. Citado por Diamond LK (71).

71. Diamond LK, Wang WC,Alter BP. Congenital hypoplastic anemia. Adv Pediatr 1976; 102:349.

72. Diamond LK, Blackfan KD. Hypoplastic anemia. Am J Dis Child 1938; 56:464.

73. Bello A, Dorantes AS, Alvarez AC. La anemia hipoplástica en la edad pediátrica. Bol Med Hosp Infant Mex 1983; 40:718.

74. Fisher JW. Regulation of erythropoietin production. En: Windhager EE, Giebish GH ed. Handbook in renal physiology. Washington: American Physiological Society, 1988.

75. Boineau FG, Figher JW. Hematologic abnormalities in renal disease. En: Edelmann CM, ed. Pediatric kidney disease. Second ed. Boston: Little, Brown, 1992: 685-694.

76. Besarab A, McCrea JB. Anemia in ESRD patients. En: Nissenson AR, Fine RN, ed. Dialysis therapy. Second ed. Philadelphia: Hanley & Belfus, 1993: 223-225.

77. McGonigle RJS, Wallin JD, Shadduck RK, y col. Erythropoietin deficiency and inhibition of erithropoiesis in renal insufficiency. Kidney Int 1984; 25:437.

78. Radtke HW, Rege AB, Lamarche MB, y col. Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure. J Clin Invest 1981; 67:1623.

79. Ateshkadi A, Johnson CA, Zimmerman SW. Epoetin use in peritoneal dialysis patients. En: Nissenson AR, Fine RN, ed. Dialysis therapy. Second ed. Philadelphia: Hanley & Belfus, 1993: 228-231.

80. Besarab A, McCrea JB. Epoetin use in hemodialysis patients. En: Nissenson AR Fine RN, ed. Dialysis therapy. Second ed. Philadelphia: Hanley & Belfus, 1993: 225-227.

81. Van Damme-Lombaerts R, Broyer M, Businger J, Baldanf C, Stocker H. A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis . Pediatr Nephrol 1994; 8:338.

82. Remuzzi G, Rossi EC. Hematologic consequences of renal failure. En: Brenner BM,ed. Brenner & Rector The Kidney. Fifth ed. Philadelphia: WB Saunders, 1996; 2170-2186.

83. Becker PS, Lux SE. Disorders of the red cell membrane. En: Nathan DG, Oski FA, ed. Hematology of infancy and childhood. 4th ed. Philadelphia: WB Saunders, 1993; 529-633.

84. Kitatani M, Chiyo H. Localization of the spherocytosis gene to chromosome segment 8p 11.22-8p21.1. Hum Genet 1988; 78:94.

85. Agre P, Orringer EP. Deficient red cell spectrin in severe recessively inherited spherocytosis. N Engl J Med 1982; 306:115.

86. Benítez-Aranda H, Rodríguez ZMC. Anemia hemolítica autoinmune primaria en niños. Bol Med Hosp Infant Mex 1986; 43:192.

87. Schreiber AD, Gill FM, Manno CS. Autoimmune hemolytic anemia. En: Nathan DG, Oski FA, ed. Hematology of infancy and childhood.4th ed. Philadelphia: WB Saunders, 1993: 496-510.

88. Garratty G. Meehanisms of immune red cell destruction, and red cell compatibility testing. Hum Pathol 1983; 14:204.

89. Berkman SA, Rippee C. Autoimmune hemolytic anemia: the role of blood transfusion. Hosp Pract 1984; 19(diciembre):111.

90. Salama A, Mueller-Eckhardt C. Autoimmune haemolytic anaemia in childhood associated with non-complement binding IgM autoantibodies. Br J Haematol 1987; 65:67.

91. Heisel MA, Ortega JA. Faetors influencing prognosis in childhood autoimmune hemolytic anemia. Am J Pediatr Hematol Oncol 1983; 5:147.

92. Benítez-Aranda H, Bernaldez RR, Alvarez-Amaya C, Farfán CJM. Anemia hemolítica autoinmunitaria primaria en niños. Rev Med IMSS (Mex) 1983; 21:328.

93. Greenberg J, Curtis-Cohen M. Prolonged reticulocytopenia in autoimmune hemolytie anemia in ehildhood. J Pediatr 1980; 97; 784.

94. Conley CL, Lippman SM . Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med l982, 306:281.

95. Evans RS, Takahashi K, Duane TR, Payne R, Liu CK Primary thrombocytopenic purpura and acquired hemolytic anemia. Arch Intern Med 1951; 87:48.

96. Pui CH,Williams J,Wang W.Evans syndrome in childhood. J Pediatr 1980; 97:754.

97. Schreiber AD. Autoimmune hemolytic anemia. Pediatr Clin North Am 1980, 27:253.

98. Kulkarni GA, Wagner RF. The Coombs test and autoimmune hemolytic anemia. JAMA 1983; 249:1564.

99. Bussel JB, Cunningham-Rundles C. Intravenous treatment of autoimmune hemolytic anemia with very high dose gammaglobulin. Vox Sang 1986; 51:264.

100. Richmond GW, Ray Y. Initial stabilization preceding enhanced hemolysis in autoimmune hemolytic anemia treated with intravenous gammaglobulin. J Pediatr 1987; 110:917.

101. Packman CH, Leddy JP. Acquired hemolytic anemia due to warmreacting autoantibodies. En: Beutler E, Lichtman MA, Coller BS, Kipps TJ, ed. Williams Hematology. Fifth ed. New York: McGraw-Hill, 1995: 677-685.